Press Release 02.19.25
Jason Stirling, Pillsbury’s Global Life Sciences & Digital Health Industry Leader, focuses on corporate matters for life sciences and technology clients, with an emphasis on helping early-stage companies thrive.
Jason represents a wide array of clients, ranging from startup and emerging growth entities to established, publicly traded companies, in the life sciences, technology, software, robotics, gaming, manufacturing, and food and beverage industries. He is experienced in private and public securities offerings, convertible debt financing, angel investor financings, venture capital financings, IPOs, mergers and acquisitions, technology licensing, joint ventures and collaborations, equity incentives and corporate governance matters.
Representative Experience
- Represented a distribution company in its $70 million acquisition by a strategic acquirer.
- Advised a franchise system in its $240 million acquisition by a private equity firm.
- Represented a chemical and diagnostics manufacturer in its $142 million acquisition by a China state-owned entity.
Professional Highlights
Presented “Crowdfunding Primer: Startups, the Internet and Money” at Pillsbury CLE Marathon events in San Diego and Los Angeles.
Education
-
J.D., University of San Diego School of Law, 2004
cum laude, Order of the Coif; San Diego International Law JournalB.S., University of California, Berkeley, 1996
Admissions
-
California
Jason’s Insights
Press Release 02.03.25
Press Release 05.07.24
Pillsbury Provides Strategic Advice for Sentynl Therapeutics’ Acquisition of Global Rights to Zokinvy® for Treatment of Progeria
Zokinvy is approved in the U.S. (2020), European Union and Great Britain (2022) and Japan (2024) for the treatment of progeria, a collection of ultra-rare, fatal, genetic premature aging diseases that accelerate mortality in young patients
Press Release 01.09.24
Press Release 11.14.23
Press Release 11.14.23
Press Release 11.06.23
Sponsor 06.05.23
Media Coverage 12.14.22
Press Release 06.09.22
Press Release 03.08.22
Media Coverage 08.24.21
Press Release 07.09.21
Press Release 11.13.20
Press Release 06.23.20
Media Coverage 09.17.19
Media Coverage 06.15.17
Media Coverage 07.12.16
Press Release 03.28.16
Press Release 12.10.15